CROs in the United Kingdom

The United Kingdom offers a robust environment for clinical research, supported by the National Health Service (NHS) which provides access to a large, diverse patient population and standardised healthcare records. The presence of world-class academic institutions, research facilities, and organisations like the National Institute for Health Research (NIHR) creates a strong infrastructure for conducting high-quality clinical trials.

However, post-Brexit regulatory changes have introduced some complexity to multi-centre European trials, with the UK now requiring separate submissions and approvals from the EU system. Despite these challenges, the UK maintains a favourable research environment with well-established ethical frameworks, competitive study start-up times, and strong governmental support for life sciences research through initiatives like the Life Sciences Vision.

Here you can find a break down of emerging, medium and large full-service UK based clinical research organizations (CROs) conducting and managing phase I-IV clinical trials.

IQVIA

A global leading full-service CRO with significant operations in the United Kingdom and worldwide, with over 40 years of experience in clinical research and healthcare intelligence. IQVIA offer comprehensive clinical development services, leveraging an extensive network of offices and staff across more than 100 countries. Services encompass clinical operations, project management, regulatory affairs, clinical data management, biostatistics, pharmacovigilance, and medical writing, supported by cutting-edge technology and analytics platforms.

IQVIA serve a diverse client base ranging from emerging biotech start-ups to global pharmaceutical companies, medical device manufacturers, and healthcare providers. Harnessing a unique combination of data, technology, services, and human expertise, to deliver actionable insights and end-to-end clinical development solutions that drive healthcare forward. Their UK presence includes major operational hubs in London, Brighton, and Reading, supported by regional offices and a network of experienced clinical research professionals across the country. They specialise in integrating real-world evidence with clinical research to accelerate drug development and improve patient outcomes.

Parexel

A leading global full-service CRO with major operations in the United Kingdom, anchored by its significant presence in Uxbridge, London, and Nottingham, with over 40 years of experience in biopharmaceutical services and clinical research. The organization offers comprehensive clinical development solutions, leveraging its extensive global infrastructure and network of experts across more than 95 countries. Their services span the entire drug development continuum including clinical operations, project management, regulatory consulting and submissions, data management, biostatistics, pharmacovigilance, and medical writing, enhanced by innovative technology solutions and patient-centric approaches.

Parexel serves a diverse portfolio of clients from emerging biotechs to large pharmaceutical companies, supporting simple to complex clinical trials across all therapeutic areas. With their Parexel Biotech division, they provide tailored solutions for small and emerging companies, while their consulting services offer strategic guidance throughout the drug development journey. The UK operations are supported by a network of experienced clinical research professionals and state-of-the-art facilities, allowing them to deliver both local expertise and global capabilities to accelerate drug development and improve patient outcomes.

PPD part of Thermo Fisher Scientific

A global leading full-service CRO with significant operations in the United Kingdom, centered around its major facilities in Cambridge, Granta Park, and multiple regional offices across the country. The organisation brings over 35 years of experience in clinical research and drug development services. Through its integration with Thermo Fisher Scientific in 2021, PPD offers enhanced capabilities combining comprehensive clinical research services with laboratory and scientific expertise. The organization provides end-to-end clinical development solutions, including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing, supported by advanced technology platforms and digital solutions.

PPD serves a broad spectrum of clients from biotechnology start-ups to global pharmaceutical companies, delivering expertise across all phases of clinical development and therapeutic areas. Their dedicated biotech solutions group provides specialized support for emerging companies, while their laboratory services offer integrated testing capabilities. The UK operations feature state-of-the-art facilities and a extensive network of experienced clinical research professionals, enabling PPD to deliver both local expertise and global reach to accelerate drug development timelines and enhance patient outcomes. The organization's capabilities are further strengthened by access to Thermo Fisher Scientific's comprehensive laboratory and analytical services network.

Syneos

A leading global full-service CRO with significant operations in the United Kingdom, based primarily in London and Farnborough. The organization was formed through the merger of INC Research and inVentiv Health in 2017, bringing together more than 30 years of clinical research expertise with comprehensive commercial capabilities. As the world's only Biopharmaceutical Accelerator, Syneos Health offers an integrated end-to-end solution that combines clinical development with commercial and consulting services. The organization provides comprehensive clinical research services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing, enhanced by their proprietary technology platforms and data-driven insights.

Syneos Health serves a diverse range of clients from emerging biotechnology companies to large pharmaceutical organizations, supporting trials across all phases and therapeutic areas. Their distinctive model integrates clinical and commercial expertise, enabling accelerated product development through synchronized solutions. The UK operations are supported by an extensive network of experienced professionals and cutting-edge infrastructure, allowing Syneos Health to deliver both local expertise and global capabilities. The organization's therapeutic expertise spans across multiple areas including oncology, rare diseases, CNS, and infectious diseases, supported by dedicated therapeutic units and specialist teams.

ICON

A leading global full-service CRO with significant operations in the United Kingdom, operating from key facilities in London, Manchester, and multiple regional offices throughout the country. With over 30 years of experience in clinical research, the organization has established itself as one of the world's largest providers of outsourced drug and device development services. ICON offers comprehensive clinical development and commercialization solutions, including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing, all supported by advanced technology platforms and digital innovations.

The organization serves a diverse client base ranging from emerging biotechnology companies to global pharmaceutical corporations, delivering expertise across all phases of clinical development and therapeutic areas. Following the acquisition of PRA Health Sciences in 2021, ICON's capabilities have been further enhanced, particularly in the areas of decentralized clinical trials, real-world evidence, and data-driven solutions. Their UK operations feature state-of-the-art facilities and an extensive network of experienced clinical research professionals, enabling the delivery of both local expertise and global reach. ICON's therapeutic expertise spans multiple areas including oncology, rare diseases, CNS disorders, and cardiovascular diseases, supported by dedicated therapeutic units and specialist teams.

Simbec-Orion

A mid-sized full-service CRO headquartered in Wales, United Kingdom, with additional operational facilities in France and Italy. The organization was formed in 2014 through the merger of Simbec Research and Orion Clinical Services, combining over 40 years of clinical research experience. As one of the largest European-based CROs, Simbec-Orion provides comprehensive clinical development services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing. The organization's services are supported by a dedicated Phase I unit in Wales and extensive capabilities in both early and late phase clinical development.

Simbec-Orion specializes in serving small to mid-sized biotechnology and pharmaceutical companies, offering tailored solutions and a high-touch, personalized approach to clinical development. Their expertise spans multiple therapeutic areas with particular strength in rare diseases, oncology, and respiratory conditions. UK operations include state-of-the-art clinical facilities and dedicated research units, supported by an experienced team of clinical research professionals.

MAC Clinical Research

An established full-service CRO headquartered in Manchester, United Kingdom, with multiple dedicated research clinics across the country including facilities in Lancashire, Merseyside, South Yorkshire, and Staffordshire. Founded in 1988, the organization has over 30 years of experience in clinical research and specializes in both early and late phase clinical trials. MAC Clinical Research provides comprehensive clinical development services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing. The organization's unique infrastructure includes purpose-built research facilities with dedicated Phase I units, sleep units, and specialist clinical trial centers. Their service offering extends from First-in-Human studies through to Phase IV trials and real-world evidence studies. MAC Clinical Research has particular expertise in CNS disorders, pain, psychiatry, neurology, and vaccines, supported by specialist therapeutic teams and experienced investigators.

The organization maintains one of the UK's largest patient databases and volunteer panels, enabling efficient patient recruitment across multiple therapeutic areas. Their dedicated research facilities are equipped with state-of-the-art technology and staffed by experienced healthcare professionals, physicians, and research experts. MAC Clinical Research serves a diverse client base including pharmaceutical companies, biotechnology firms, and academic institutions, offering a flexible and personalized approach to clinical development with the capability to conduct both simple and complex clinical trials.

Worldwide Clinical Trials

A global full-service CRO with significant operations in the United Kingdom, centered around its facilities in High Wycombe, Nottingham, and London. Established in 1986, the organization brings over 35 years of experience in clinical research and drug development. Worldwide Clinical Trials provides comprehensive clinical development services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing, supported by advanced technology platforms and innovative solutions. The organization has particular expertise in complex therapeutic areas including neuroscience, cardiovascular, immune-mediated inflammatory disorders, and rare diseases. Their dedicated scientific and medical experts provide strategic guidance throughout the drug development process, from protocol development through to regulatory submission.

Worldwide Clinical Trials serves a diverse range of clients from emerging biotechnology companies to large pharmaceutical organizations, offering a unique blend of scientific expertise and operational excellence. The organization's UK operations feature experienced research teams and established site networks, enabling efficient study delivery and high-quality data generation. Their approach combines the attention and flexibility often associated with a smaller CRO while maintaining the global reach and sophisticated capabilities of larger organizations. The organization is known for its therapeutic area expertise, particularly in neuroscience and rare disease research, where they have contributed to numerous groundbreaking studies and drug approvals.

Ergomed

A specialized full-service CRO headquartered in Guildford, United Kingdom, with additional offices across Europe and the United States. Founded in 1997, the organization has built a strong reputation over 25 years in clinical research, with particular expertise in pharmacovigilance and rare disease studies. Through strategic acquisitions including PrimeVigilance and MedSource, Ergomed provides comprehensive clinical development services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing. The organization's services are enhanced by its proprietary clinical trial management technology and dedicated study physician teams. Ergomed specializes in complex therapeutic areas including oncology, rare diseases, and drug safety, offering tailored solutions for pharmaceutical and biotechnology companies of all sizes.

Their distinctive site management model and study physician teams enable high-quality patient recruitment and retention, particularly in rare disease studies. The organization's pharmacovigilance division, PrimeVigilance, provides comprehensive drug safety services across the product lifecycle. Ergomed's UK operations include state-of-the-art facilities and an extensive network of experienced clinical research professionals, enabling the delivery of both local expertise and global reach. The organization maintains a patient-centric approach throughout all its services, supported by strategic relationships with patient advocacy groups and key opinion leaders in specialized therapeutic areas.

Allucent

A global full-service CRO with significant operations in the United Kingdom based in Reading. Allucent provides comprehensive clinical development services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing, supported by innovative technology platforms and digital solutions. The organization specializes in supporting small to mid-sized biotechnology and pharmaceutical companies, offering tailored solutions that combine traditional clinical research approaches with modern decentralized trial capabilities. Their expertise spans multiple therapeutic areas with particular strength in rare diseases, oncology, and complex trials. The organization's technology-enabled solutions include advanced risk-based monitoring, quality management systems, and hybrid trial designs.

Allucent's UK operations feature experienced research teams and established site networks, enabling efficient study delivery and high-quality data generation. The organization's approach combines deep therapeutic expertise with innovative technology solutions to accelerate clinical development timelines while maintaining quality and regulatory compliance.

Richmond Pharmacology

A specialized CRO headquartered in London, United Kingdom, with state-of-the-art clinical research facilities in Croydon and Richmond. Founded in 2001, the organization has over 20 years of experience specializing in early phase clinical trials and clinical pharmacology studies. Richmond Pharmacology provides comprehensive early phase development services including protocol development, clinical operations, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing. The organization operates one of the largest Phase I units in the UK, with a capacity of over 100 beds across its clinical facilities, equipped with intensive cardiac monitoring capabilities and emergency response systems. Their expertise spans multiple therapeutic areas with particular strength in cardiac safety assessment, ethnic bridging studies, and first-in-human trials.

The organization maintains a database of over 150,000 volunteers and specialized patient groups, enabling efficient recruitment for both healthy volunteer and patient studies. Richmond Pharmacology's facilities feature dedicated research units staffed by experienced physicians, nurses, and clinical research professionals, operating 24/7 to support complex study designs and time-critical assessments. The organization serves a diverse client base including pharmaceutical companies, biotechnology firms, and academic institutions, offering specialized expertise in challenging early phase studies including SAD/MAD, drug-drug interaction, and thorough QT studies. Their scientific expertise is complemented by a strong focus on quality and regulatory compliance, demonstrated by successful regulatory authority inspections and audits.

Caidya

A global full-service CRO with strategic operations in the United Kingdom, operating from facilities across the country. The organization, formed from the integration of established CRO businesses, brings together decades of clinical research expertise with modern technological capabilities. Caidya provides comprehensive clinical development services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing, all supported by advanced technology platforms and data-driven solutions. The organization specializes in delivering tailored clinical development programs across multiple therapeutic areas, with particular expertise in oncology, rare diseases, and complex clinical trials. Their service offering encompasses all phases of clinical research, from early phase through post-marketing studies, enhanced by capabilities in decentralized clinical trials and real-world evidence generation.

Caidya serves a diverse range of clients from emerging biotechnology companies to global pharmaceutical organizations, providing flexible solutions that can scale with client needs. The organization's UK operations feature experienced research teams and established site networks, enabling efficient study delivery and high-quality data generation. Their approach combines scientific expertise with operational excellence, supported by a global infrastructure and local knowledge.

TCR Solutions

A specialized CRO headquartered in London, United Kingdom, providing focused clinical research support and expertise. Established in 2015, the organization brings extensive experience in clinical trial delivery and management across multiple therapeutic areas. TCR Solutions provides comprehensive clinical development services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing, supported by modern technology platforms and quality management systems. The organization specializes in providing flexible, tailored solutions for small to medium-sized pharmaceutical and biotechnology companies, with particular expertise in study start-up optimization and site management. Their services encompass all phases of clinical research, with additional strength in rescue studies and performance improvement initiatives.

TCR Solutions serves a diverse client base across the UK and Europe, offering personalized attention and scalable solutions that adapt to specific sponsor needs. The organization's UK operations feature experienced research teams and established site networks, enabling efficient study delivery and high-quality data generation. Their approach combines practical operational experience with strategic oversight, supporting clients from protocol development through to final reporting. The organization maintains expertise across multiple therapeutic areas, with particular strength in oncology and rare diseases. TCR Solutions' commitment to quality and efficiency is demonstrated through their track record of successful study delivery and process optimization, supported by experienced clinical research professionals who provide hands-on support throughout the clinical development process.

SGS Life Sciences

A global full-service CRO, operating as part of SGS Group, with significant operations in the United Kingdom based primarily in Surrey. The organization brings over 40 years of experience in life sciences and clinical research, leveraging the broader SGS Group's extensive quality control and testing expertise. SGS Life Sciences provides comprehensive clinical development services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing. The organization's services are enhanced by an extensive global laboratory network, offering integrated bioanalytical, biomarker, and central laboratory services. Their expertise spans all phases of clinical development, from early phase through post-marketing studies, with particular strength in bioanalysis, biosafety testing, and complex clinical trials.

The organization serves a diverse client base including pharmaceutical, biotechnology, and medical device companies, offering tailored solutions that combine clinical expertise with laboratory testing capabilities. SGS Life Sciences' UK operations feature state-of-the-art facilities and experienced research teams, enabling the delivery of both local expertise and global reach. The organization maintains specialized capabilities in biologics, cell and gene therapies, and vaccines, supported by dedicated expert teams and advanced analytical platforms. Their integrated approach combines clinical research services with comprehensive laboratory testing capabilities, providing clients with end-to-end solutions for their development programs while maintaining high quality and regulatory compliance standards.

Quanticate

A data-focused CRO headquartered in Hitchin, United Kingdom, with additional operational facilities across Europe, North America, and India. Founded in 2007, the organization brings over 15 years of experience focusing on clinical data services and biometrics. Quanticate provides comprehensive clinical trial data services including clinical data management, biostatistics, statistical programming, medical writing, and pharmacovigilance, supported by cutting-edge technology platforms and quality management systems. The organization specializes in complex data analytics and reporting solutions, offering particular expertise in clinical trial rescue situations and regulatory submissions. Their services span all phases of clinical research, with specialized capabilities in data standardization, CDISC compliance, and regulatory reporting.

Quanticate serves a diverse client base from biotechnology startups to global pharmaceutical companies, providing flexible resourcing models that can adapt to varying project needs. The organization's UK operations feature specialized teams of statisticians, programmers, and data managers, enabling delivery of high-quality data solutions and regulatory-compliant submissions. Their centralized biometrics approach ensures consistency and efficiency across projects while maintaining high quality standards. Quanticate's dedication to data integrity and regulatory compliance is demonstrated through successful regulatory authority inspections and a track record of supporting multiple drug approvals. The organization maintains expertise across multiple therapeutic areas, with particular strength in oncology, rare diseases, and complex clinical trials.

Medical Research Network (MRN)

A specialized CRO headquartered in Milton Keynes, United Kingdom, with an established global presence. Founded in 2006, the organization has pioneered decentralized clinical trials and home healthcare services in clinical research for over 15 years. MRN provides comprehensive decentralized clinical trial services including clinical operations, project management, regulatory affairs, data management, and home healthcare solutions. The organization specializes in bringing clinical trials to patients' homes, reducing the burden of trial participation while maintaining high-quality data collection and patient safety standards. Their services include mobile research nursing, home health services, remote data collection, and hybrid trial solutions. The organization maintains a vast network of qualified research nurses and healthcare professionals across multiple countries, enabling global trial delivery in patients' homes.

MRN serves pharmaceutical, biotechnology, and medical device companies of all sizes, offering solutions that range from single-patient home visits to complete decentralized trial management. The organization's UK operations feature experienced clinical teams, project managers, and a sophisticated logistics infrastructure that ensures reliable delivery of clinical trial services. Their expertise spans multiple therapeutic areas, with particular strength in rare diseases, oncology, and chronic conditions where patient mobility may be limited.

Acceler8 Clinical Research

An emerging full-service CRO headquartered in the United Kingdom, with strategic operations across key regions. Founded by experienced industry professionals, the organization combines established clinical research expertise with innovative approaches to trial delivery. Acceler8 provides comprehensive clinical development services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing, supported by modern technology platforms and quality management systems. The organization specializes in accelerating clinical development through streamlined processes and innovative trial designs, with particular expertise in startup optimization and patient recruitment strategies. Their services span all phases of clinical research, offering tailored solutions that adapt to specific sponsor needs and trial requirements.

Acceler8 serves both emerging biotechnology companies and established pharmaceutical organizations, providing flexible, scalable solutions that maintain quality while reducing development timelines. The organization's UK operations feature experienced research teams and established site networks, enabling efficient study delivery and high-quality data generation. Their therapeutic expertise spans multiple areas including oncology, rare diseases, and complex clinical trials, supported by dedicated therapeutic units and specialist teams.

Advanced Clinical

A global mid-sized CRO with established operations in the United Kingdom, operating from strategic locations across the country. Founded in 1994, the organization brings over 25 years of experience in clinical research and functional service provision. Advanced Clinical provides comprehensive clinical development services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing, supported by modern technology platforms and quality management systems. The organization offers a unique combination of CRO services and specialized staffing solutions, enabling flexible resourcing models tailored to sponsor needs. Their expertise spans multiple therapeutic areas with particular strength in oncology, rare diseases, and medical devices.

Serving a diverse range of clients from emerging biotechnology companies to global pharmaceutical organizations, offering scalable solutions that maintain high-quality standards while optimizing resource utilization. Advanced Clinical's UK operations feature experienced research teams and established site networks, enabling efficient study delivery and high-quality data generation. Their approach combines the personal attention and flexibility of a mid-sized CRO with sophisticated capabilities and global reach. Advanced Clinical maintains expertise in complex trial designs and specialized therapeutic areas, delivering both full-service clinical research and functional service provider solutions.

Lambda Therapeutic Research

A global full-service CRO with significant operations in the United Kingdom, based in London and West London. Established in 2002, the organization brings over 20 years of experience specializing in early phase clinical research and bioanalytical services. Lambda provides comprehensive clinical development services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing, supported by state-of-the-art clinical facilities and bioanalytical laboratories. The organization specializes in early phase studies, particularly First-in-Human, bioavailability/bioequivalence, and clinical pharmacology studies, with dedicated Phase I units equipped with intensive cardiac monitoring capabilities and emergency response systems. Their expertise extends to complex study designs including drug-drug interaction studies, thorough QT studies, and patient studies in various therapeutic areas.

Lambda serves a diverse client base including pharmaceutical companies, biotechnology firms, and generic drug manufacturers, offering integrated solutions that combine clinical research with advanced bioanalytical capabilities. The organization's UK operations feature purpose-built clinical facilities and experienced research teams, enabling efficient study delivery and high-quality data generation. Their bioanalytical laboratories are equipped with advanced LC-MS/MS instruments and other sophisticated analytical platforms, supporting method development, validation, and sample analysis. Lambda's commitment to quality and regulatory compliance is demonstrated through successful regulatory authority inspections and accreditations from major global regulatory bodies.

Onorach

A specialized full-service CRO headquartered in Dundee, Scotland, with operations across the United Kingdom. Founded in 2009, the organization brings over a decade of experience in clinical research and regulatory consulting. Onorach provides comprehensive clinical development services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing, supported by quality management systems and established processes. The organization specializes in supporting small to medium-sized pharmaceutical, biotechnology, and medical device companies, offering particular expertise in early phase clinical trials and regulatory strategy. Their services encompass all phases of clinical development, with additional strength in medical device trials and combination products.

Onorach serves clients across Europe and North America, providing personalized attention and flexible solutions tailored to specific sponsor needs. The organization's UK operations feature experienced research teams and strong relationships with clinical sites and key opinion leaders. Their approach combines scientific expertise with practical regulatory knowledge, supporting clients from early development through to marketing authorization. Onorach maintains specialized expertise in complex trial designs and challenging therapeutic areas, with a focus on rare diseases and innovative medical technologies. Their commitment to quality and regulatory compliance is demonstrated through successful regulatory authority inspections and a track record of supporting multiple product approvals.

PHARMExcel

A specialized full-service CRO headquartered in Stevenage, United Kingdom, with additional operations across Europe. Founded in 2009, the organization brings over a decade of experience in clinical research management and consultancy services. PHARMExcel provides comprehensive clinical development services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing, supported by robust quality management systems and established processes. The organization specializes in supporting small to medium-sized pharmaceutical companies, biotechnology firms, and academic institutions, offering particular expertise in complex trial designs and challenging therapeutic areas. Their services span all phases of clinical development, with additional strength in rescue studies and regulatory strategy.

PHARMExcel serves a diverse client base, providing personalized attention and flexible solutions that can adapt to varying project needs and budgets. The organization's UK operations feature experienced research teams and established site networks, enabling efficient study delivery and high-quality data generation. Their approach combines scientific expertise with practical operational experience, supporting clients from protocol development through to final study reporting. PHARMExcel maintains expertise across multiple therapeutic areas, with particular strength in oncology, rare diseases, and medical devices. The organization's commitment to quality and regulatory compliance is demonstrated through their track record of successful regulatory submissions and inspections, supported by a dedicated team of clinical research professionals who provide hands-on support throughout the clinical development process.

The Micron Group

A specialized CRO headquartered in the United Kingdom, with strategic operations primarily focused on clinical pharmacology. Founded in 1997, the organization brings over 25 years of experience in early phase clinical research and medical communications. The Micron Group provides comprehensive early phase clinical research services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing, supported by modern technology platforms and quality management systems. The organization specializes in Phase I and early phase clinical trials, offering purpose-built clinical facilities and specialized capabilities for complex study designs. Their services include First-in-Human studies, drug-drug interaction studies, bioavailability/bioequivalence assessments, and patient studies in various therapeutic areas.

The Micron Group serves pharmaceutical companies, biotechnology firms, and academic institutions, providing integrated solutions that combine clinical expertise with scientific communications. The organization's UK operations feature state-of-the-art clinical units and experienced research teams, enabling efficient study delivery and high-quality data generation. Their approach combines scientific rigor with operational excellence, supported by dedicated medical and clinical experts. The organization maintains particular expertise in clinical pharmacology, complex protocol designs, and intensive pharmacokinetic sampling studies. Their commitment to quality and regulatory compliance is demonstrated through successful regulatory authority inspections and a strong track record in early phase clinical development.

TMC Pharma

A specialized CRO headquartered in Reading, United Kingdom, with additional operations across Europe and North America. Founded in 2000, the organization brings over 20 years of experience in providing strategic drug development and clinical research services. TMC Pharma provides comprehensive development services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing, supported by established quality management systems and regulatory expertise. The organization specializes in offering strategic drug development solutions for small to mid-sized pharmaceutical and biotechnology companies, with particular expertise in orphan drugs, rare diseases, and complex development programs. Their services span all phases of clinical development, from early strategic planning through to post-marketing support, with additional strength in regulatory strategy and submissions.

TMC Pharma serves a diverse international client base, offering flexible resourcing models that provide access to experienced development professionals and specialized expertise. The organization's UK operations feature experienced teams of drug development experts and project managers, enabling efficient program delivery and strategic guidance. Their approach combines strategic oversight with hands-on operational support, particularly suited to companies requiring expert guidance through complex development pathways. The organization maintains expertise across multiple therapeutic areas, with particular strength in rare diseases, oncology, and pediatric indications. TMC Pharma's commitment to quality and regulatory excellence is demonstrated through their track record of successful regulatory submissions and product approvals across multiple territories.

hVIVO

A specialized CRO headquartered in London, United Kingdom, with unique facilities dedicated to human challenge trials and early clinical development. Founded in 1989 as Retroscreen Virology and later rebranded as hVIVO, the organization brings over 30 years of experience in viral challenge studies and respiratory research. hVIVO provides comprehensive clinical development services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing, with particular expertise in human challenge trial design and execution. The organization operates specialized quarantine facilities in London, purpose-built for conducting controlled human infection studies. Their services include viral challenge studies, early phase clinical trials, and specialized respiratory research, supported by on-site virology laboratories and clinical facilities.

hVIVO serves pharmaceutical companies, biotechnology firms, and vaccine developers, offering unique capabilities in testing vaccines and antiviral treatments through their human challenge study platform. Their expertise spans multiple respiratory viruses including influenza, RSV, and coronavirus, supported by proprietary virus manufacturing capabilities and established challenge agent characterization processes. The organization maintains an extensive volunteer database and specialized recruitment capabilities for human challenge studies. hVIVO's commitment to scientific excellence and patient safety is demonstrated through their track record of successful studies and contributions to vaccine and antiviral drug development, supported by robust quality systems and regulatory compliance standards.

Premier Research

A global full-service CRO with significant operations in the United Kingdom, based primarily in London and Reading. Founded in 1989, the organization brings over 30 years of experience in clinical research and drug development. Premier Research provides comprehensive clinical development services including clinical operations, project management, regulatory affairs, data management, biostatistics, pharmacovigilance, and medical writing, supported by advanced technology platforms and quality management systems. The organization specializes in rare disease research, pediatric studies, and complex therapeutic areas including neuroscience, oncology, and cell and gene therapy. Their expertise spans all phases of clinical development, with particular strength in rare disease patient recruitment and innovative trial designs.

Premier Research serves a diverse range of clients from emerging biotechnology companies to established pharmaceutical organizations, offering tailored solutions that combine scientific expertise with operational excellence. The organization's UK operations feature experienced research teams and established site networks, enabling efficient study delivery and high-quality data generation. Their approach combines therapeutic area expertise with patient-centric trial designs, supported by dedicated patient recruitment and retention strategies. The organization maintains specialized capabilities in biostatistics and data management, with expertise in complex trial designs and adaptive protocols. Premier Research's commitment to quality and innovation is demonstrated through their investment in technology solutions and patient engagement strategies aimed at accelerating drug development while maintaining rigorous scientific standards and regulatory compliance.